These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators. Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG. J Am Coll Cardiol; 2005 Dec 20; 46(12):2258-63. PubMed ID: 16360055 [Abstract] [Full Text] [Related]
33. Inappropriate inhibition of biventricular pacing due to diaphragmatic myopotentials amplified by the selectable sensing filter. Iijima K, Ishida N, Izumi D, Minamino T. Europace; 2017 Dec 01; 19(12):2014. PubMed ID: 28340033 [No Abstract] [Full Text] [Related]
34. Tpeak - Tend and Tpeak - Tend /QT ratio as markers of ventricular arrhythmia risk in cardiac resynchronization therapy patients. Barbhaiya C, Po JR, Hanon S, Schweitzer P. Pacing Clin Electrophysiol; 2013 Jan 01; 36(1):103-8. PubMed ID: 23106253 [Abstract] [Full Text] [Related]
38. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Palmisano P, Accogli M, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S. Europace; 2013 Apr 01; 15(4):531-40. PubMed ID: 23407627 [Abstract] [Full Text] [Related]